B. Scatton

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

B. Scatton, France Javoy‐Agid, L. Rouquier et al. · Brain Research · 1983 · 723 citations

Cortical Dopamine, Psychiatry, Neurophysiology +14

Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse

Jean-Pierre Nowicki, D. Duval, H. Poignet et al. · European Journal of Pharmacology · 1991 · 504 citations

Cerebral Vascular Regulation, Neurophysiology, Nitric Oxide +15

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal et al. · Proceedings of the National Academy of Sciences · 2002 · 459 citations · Full text

Psychotropic Medication, Affective Neuroscience, Psychopharmacology +24

Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat

J.P. Herman, D. Guillonneau, Robert Dantzer et al. · Life Sciences · 1982 · 423 citations

Dopamine Turnover, Kinesiology, Neurophysiology +11

Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity

H. Schoemaker, Y. Claustre, Dominique Fage et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 372 citations · Full text